TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Clinical trials for TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES explained in plain language.

Never miss a new study

Get alerted when new TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES trials appear

Sign up with your email to follow new studies for TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer drug shows promise for rare vascular conditions in kids and young adults

Disease control Ongoing

This study tests the drug alpelisib (already approved for some breast cancers) in people aged 2 months to 30 years with rare blood vessel growth disorders caused by specific gene changes. Participants take the drug for at least 2 years, and researchers measure improvement using s…

Matched conditions: TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control

Last updated May 11, 2026 20:54 UTC

TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES

Get alerted when new TIE2/PIK3CA PATHWAY DRIVEN VASCULAR ANOMALIES trials appear

Cancer drug shows promise for rare vascular conditions in kids and young adults